Works matching AU Shao, Jimin


Results: 23
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma.

    Published in:
    Journal of Biomedical Science, 2022, v. 29, n. 1, p. 1, doi. 10.1186/s12929-022-00813-2
    By:
    • Xie, Yongsheng;
    • Wang, Yingcong;
    • Xu, Zhijian;
    • Lu, Yumeng;
    • Song, Dongliang;
    • Gao, Lu;
    • Yu, Dandan;
    • Li, Bo;
    • Chen, Gege;
    • Zhang, Hui;
    • Feng, Qilin;
    • Zhang, Yong;
    • Hu, Ke;
    • Huang, Cheng;
    • Peng, Yu;
    • Wu, Xiaosong;
    • Mao, Zhiyong;
    • Shao, Jimin;
    • Zhu, Weiliang;
    • Shi, Jumei
    Publication type:
    Article
    15

    Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma.

    Published in:
    Journal of Biomedical Science, 2022, v. 29, n. 1, p. 1, doi. 10.1186/s12929-022-00813-2
    By:
    • Xie, Yongsheng;
    • Wang, Yingcong;
    • Xu, Zhijian;
    • Lu, Yumeng;
    • Song, Dongliang;
    • Gao, Lu;
    • Yu, Dandan;
    • Li, Bo;
    • Chen, Gege;
    • Zhang, Hui;
    • Feng, Qilin;
    • Zhang, Yong;
    • Hu, Ke;
    • Huang, Cheng;
    • Peng, Yu;
    • Wu, Xiaosong;
    • Mao, Zhiyong;
    • Shao, Jimin;
    • Zhu, Weiliang;
    • Shi, Jumei
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23